Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

February 13, 2018

Kim v. Cascadian Therapeutics, Inc. et al

Track this case

Case Number:

1:18-cv-00250

Court:

Delaware

Nature of Suit:

Stockholders Suits

Multi Party Litigation:

Class Action

Judge:

Colm F. Connolly

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 14, 2018

    Cascadian Investor Says $614M Deal Statement Omitted Info

    A shareholder of biopharmaceutical company Cascadian Therapeutics Inc. launched a class action on Tuesday in Delaware federal court alleging the company's directors omitted material information from documents detailing a proposed $614 million merger deal with Seattle Genetics Inc.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login